## Abstract We describe a patient with cerebellar ataxia of degenerative nature who was administered high‐dose piracetam in a single‐blind trial. Piracetam was demonstrated to be highly effective on tandem gait and gait ataxia in daily doses of 60 g. We suggest piracetam has a potential anti‐ataxic
Shortening reaction in patients with cerebellar ataxia
✍ Scribed by Dr. Ronald W. Angel
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 678 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
During passive extension of the elbow, the triceps muscle normally shows a burst of electromyographic activity. This shortening reaction (SR) is known to be exaggerated in extrapyramidal disease states, but the effects of cerebellar disease are unknown. The SR was measured in both arms of a patient with hemiataxia, the unaffected arm serving as a matched control. In the ataxic arm, the SR was significantly larger and did not show the normal increase during “reinforcement.” In a patient with bilateral ataxia, the SR was grossly exaggerated as compared with the SRs in a group of normal subjects. The present findings indicate an unexpected point of similarity between cerebellar and extrapyramidal disease states, which is discussed in terms of the anatomical connections of the cerebellum and basal ganglia. The techniques used in this work provide a quantitative approach to disorders of movement and muscle tone.
📜 SIMILAR VOLUMES
## Abstract To determine the economic burden (direct and indirect costs), as well as health‐related quality of life (HRQOL) in patients diagnosed with spinocerebellar ataxia (SCA) in Spain. A cross‐sectional study was carried out on 84 patients with SCA from the Spanish Ataxia Federation (FEDAES) d
## Abstract We investigated whether quantified measurements of trunk sway during stance and gait tests in patients with autosomal dominant spinocerebellar ataxia (SCA) could be a useful approach to assess ataxia, which is highly relevant for adequate follow‐up and future intervention studies. Exami
## Abstract Friedreich ataxia is an inherited, progressive, neurodegenerative disorder that is clinically heterogeneous. It is caused by a trinucleotide (GAA) repeat expansion resulting in frataxin loss and oxidative stress. We assessed clinical features including the development of cardiomyopathy